Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Manabe

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Case Reports in Nephrology and Dialysis|April 8, 2015
Bucillamine-induced membranous nephropathy with crescent formation in a patient with rheumatoid arthritis: case report and literature reviewShun Manabe, Mayuko Banno, Marie Nakano, et al.
Kidney Medicine|June 17, 2021
Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry DiseaseShun Manabe, Toshio Mochizuki, Masayo Sato, et al.
Clinical and Experimental Nephrology|April 29, 2026
Attribute-based cross-classification reveals sex- and age-specific prognostic impact of anemia in ADPKDKosaku Nitta, Hiroshi Kataoka, Yusuke Ushio, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
BMC Nephrology|March 18, 2026
Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysisHaruka Kato, Takashi Yokoyama, Shun Manabe, et al.
Clinical and Experimental Nephrology|September 25, 2024
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney diseaseKosaku Nitta, Hiroshi Kataoka, Shun Manabe, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Kidney360|April 4, 2022
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney DiseaseTaro Akihisa, Shun Manabe, Hiroshi Kataoka, et al.
The American Journal of Pathology|June 15, 2015
Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosisSatoshi Hara, Namiko Kobayashi, Kazuo Sakamoto, et al.
Internal Medicine (Tokyo, Japan)|October 14, 2021
Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen StainingMasayo Sato, Shun Manabe, Mitsuyo Itabashi, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Case Reports in Nephrology and Dialysis|April 8, 2015
Bucillamine-induced membranous nephropathy with crescent formation in a patient with rheumatoid arthritis: case report and literature reviewShun Manabe, Mayuko Banno, Marie Nakano, et al.
Kidney Medicine|June 17, 2021
Lupus Nephritis and Hydroxychloroquine-Associated Zebra Bodies: Not Just in Fabry DiseaseShun Manabe, Toshio Mochizuki, Masayo Sato, et al.
Clinical and Experimental Nephrology|April 29, 2026
Attribute-based cross-classification reveals sex- and age-specific prognostic impact of anemia in ADPKDKosaku Nitta, Hiroshi Kataoka, Yusuke Ushio, et al.
Kidney International Reports|September 13, 2021
Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKDShiho Makabe, Shun Manabe, Hiroshi Kataoka, et al.
BMC Nephrology|March 18, 2026
Clinical awareness and targeted manual urine microscopy enable diagnosis of a fabry disease family missed by routine urinalysisHaruka Kato, Takashi Yokoyama, Shun Manabe, et al.
Clinical and Experimental Nephrology|September 25, 2024
Association of hyperphosphatemia with renal prognosis in patients with autosomal dominant polycystic kidney diseaseKosaku Nitta, Hiroshi Kataoka, Shun Manabe, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Kidney360|April 4, 2022
Dose-Dependent Effect of Tolvaptan on Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney DiseaseTaro Akihisa, Shun Manabe, Hiroshi Kataoka, et al.
The American Journal of Pathology|June 15, 2015
Podocyte injury-driven lipid peroxidation accelerates the infiltration of glomerular foam cells in focal segmental glomerulosclerosisSatoshi Hara, Namiko Kobayashi, Kazuo Sakamoto, et al.
Internal Medicine (Tokyo, Japan)|October 14, 2021
Slowly Progressive Male Alport Syndrome Evaluated by Serial Biopsy: Importance of Type IV Collagen StainingMasayo Sato, Shun Manabe, Mitsuyo Itabashi, et al.
Pageof 5